CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.
August 25th 2023, 1:00pm
Progression-free survival improved with Retevmo as the initial treatment for patients with advanced RET-mutant medullary thyroid cancer.
May 12th 2022, 1:00pm
Before closing out their discussion on differentiated thyroid cancer, patients and health care professionals alike consider unmet needs in this space.
May 5th 2022, 1:15pm
A brief discussion on therapeutic options one may consider after progression on lenvatinib therapy for iodine-refractory DTC.
May 5th 2022, 1:00pm
Shared practical advice for patients who may be undergoing treatment for iodine-refractory differentiated thyroid cancer.
April 28th 2022, 1:20pm
Discussion on how best to communicate with care providers while undergoing therapy for iodine-refractory differentiated thyroid cancer.
April 28th 2022, 1:00pm
Considerations for how dosing and dose reductions can be used to optimize use of lenvatinib for iodine-refractory DTC.
April 21st 2022, 1:15pm
Expert and patient perspectives on receiving lenvatinib therapy for iodine-refractory differentiated thyroid cancer.
April 21st 2022, 1:00pm
Health care specialists share insight on the work-up of patients with iodine-refractory differentiated thyroid cancer and how this may affect systemic therapy options.
April 15th 2022, 3:00pm
From a Netflix star revealing a breast cancer diagnosis to “Good Morning America” host Robin Roberts sharing what emotions she felt when partner Amber Laign was diagnosed with breast cancer, here’s what is happening in the cancer space this week.
April 14th 2022, 1:15pm
Discussion on when differentiated thyroid cancer is determined to be iodine-refractory, and how patients should be followed in this setting.
First Patient Dosed With Annamycin and Cytarabine in Phase 3 AML Trial
Second-Line Tovecimig Elicits Responses in Biliary Tract Cancer
Tagrisso May Improve Survival in Advanced EGFR-Mutant NSCLC
Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care